Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in loss of ARID1A-protein expression and frequently co-occur with PI3K/AKT-pathway activating mechanisms. The aim of this study w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Samartzis, Eleftherios P, Gutsche, Katrin, Dedes, Konstantin J, Fink, Daniel, Stucki, Manuel, Imesch, Patrick
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170604/
https://ncbi.nlm.nih.gov/pubmed/24979463
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak